Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?

BACKGROUND: The use of anticoagulants is an established strategy to prevent stroke, embolism, and cardiovascular mortality in patients with atrial fibrillation (AF), but its role in the prevention of incident diabetes is unclear. We aimed to investigate this question by using participant data from c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuyang, Feng, Shenghui, Chen, Zhuohui, Zhou, Yue, Yin, Kang, Xue, Zhengbiao, Zhu, Wengen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160370/
https://www.ncbi.nlm.nih.gov/pubmed/35665262
http://dx.doi.org/10.3389/fcvm.2022.874795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160370/
https://www.ncbi.nlm.nih.gov/pubmed/35665262
http://dx.doi.org/10.3389/fcvm.2022.874795

Ejemplares similares